Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
27 May 2022 | Story Leonie Bolleurs | Photo Charl Devenish
Prof Tomas Vetrik
Prof Tomas Vetrik, Professor in the Department of Mathematics and Applied Mathematics, recently delivered his inaugural lecture on the UFS Bloemfontein Campus.

Prof Tomas Vetrik, Professor in the Department of Mathematics and Applied Mathematics at the University of the Free State (UFS), recently delivered his inaugural lecture on the Bloemfontein Campus.

His research area is graph theory, and he mainly focuses on the degree-diameter problem, graph indices, and metric dimension of graphs.

Research focus

According to Prof Vetrik, mathematics was always his favourite subject in school. He also excelled in maths at university and decided to enrol for a course on graph theory while working on his master’s degree. “I liked it, so I also chose topics from graph theory for my PhD thesis,” he says.

In 2014, at the age of 32, he was appointed Associate Professor at the UFS, after postdoctoral research at the University of KwaZulu-Natal and working at the University of Pretoria. An NRF-rated researcher, he has published close to 75 research papers, a third of that as a single author in some of the most well-known journals in his area. Moreover, he was also research supervisor of three PhD and three master’s students.

International collaborations

In the eight years since his appointment at the UFS, Prof Vetrik has made research visits to universities from 14 different countries that have invited him for research collaborations. 

“I am often overseas. I like working from different places. It is interesting to me, and it helps me to be productive,” says Prof Vetrik, explaining some of the inspiration behind his mathematical ideas.

In the next two years, he would like to study more general mathematical problems beyond his current research area.

He says he is addicted to his research. “It overshadows all my other interests.” 

On the rare occasion when he is not working on his research, Prof Vetrik states that he has to keep himself busy. Unable to relax and do nothing, he likes to do sports of some kind or to travel. 

“I am a simple person. I do not even have a TV at home. I use an old-fashioned mobile phone that cannot access the internet,” he says.


News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept